GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹36 Cr | ₹240 Cr | ₹1,441 Cr | ₹1,382 Cr | ₹1,096 Cr |
What is the latest Profit Before Tax of GLENMARK PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹240 Cr |
| Mar2023 | ₹1,441 Cr |
| Mar2022 | ₹1,382 Cr |
| Mar2021 | ₹1,096 Cr |
How is Profit Before Tax of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | -84.78 | |
| Mar2024 | ₹240 Cr | -83.36 | |
| Mar2023 | ₹1,441 Cr | 4.25 | |
| Mar2022 | ₹1,382 Cr | 26.13 | |
| Mar2021 | ₹1,096 Cr | - | |
Compare Profit Before Tax of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹58,542.4 Cr | 1.9% | 5.5% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,319.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,383.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,241.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹123,617.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,825.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 1.9% |
5.5% |
24.4% |
| SENSEX | 0.5% |
-0.2% |
8.4% |
You may also like the below Video Courses